ZUSAMMENSETZUNG MIT BOTULINUMTOXIN

European patent · EP3423084 · In force

Register entry

Publication number
EP3423084
Application number
EP17707051
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 28, 2017
Published
Jan 9, 2019
Granted
Sep 1, 2021
Protection ends at the latest
Feb 27, 2037
Next annual fee due
Feb 28, 2027
IPC classes
A61K 38/48 (2006.01)
A61Q 19/08 (2006.01)
A61K 47/36 (2006.01)
A61K 8/64 (2006.01)
A61K 8/73 (2006.01)
A61K 9/00 (2006.01)
A61K 9/08 (2006.01)
A61P 21/00 (2006.01)
Priority
EP 16158302 02.03.2016
PCT application
PCT/EP2017/054596 28.02.2017
PCT publication
WO2017/148915 08.09.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Jul 13, 2022

    Change

    Published in Swissreg on 13.07.2022

  6. Sep 10, 2021

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 10.09.2021

  7. Sep 1, 2021

    Granted

    Published in Swissreg on 01.09.2021

Parties

Holder

Merz Pharma GmbH & Co. KGaA

Eckenheimer Landstrasse 100, 60318 Frankfurt am Main, DE

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

BODERKE, Peter

65824 Schwalbach, DE

FINK, Klaus

50968 Köln, DE

RUSS, Hermann

8852 Altendorf SZ

TAYLOR, Harold

60435 Frankfurt am Main, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.